Bacterial diversity and chemical ecology of natural product-producing bacteria from Great Salt Lake sediment.

Actinomycetota Great Salt Lake chemical ecology halophiles natural products

Journal

ISME communications
ISSN: 2730-6151
Titre abrégé: ISME Commun
Pays: England
ID NLM: 9918205372406676

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 28 11 2023
revised: 20 01 2024
accepted: 27 02 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 25 3 2024
Statut: epublish

Résumé

Great Salt Lake (GSL), located northwest of Salt Lake City, UT, is the largest terminal lake in the USA. While the average salinity of seawater is ~3.3%, the salinity in GSL ranges between 5% and 28%. In addition to being a hypersaline environment, GSL also contains toxic concentrations of heavy metals, such as arsenic, mercury, and lead. The extreme environment of GSL makes it an intriguing subject of study, both for its unique microbiome and its potential to harbor novel natural product-producing bacteria, which could be used as resources for the discovery of biologically active compounds. Though work has been done to survey and catalog bacteria found in GSL, the Lake's microbiome is largely unexplored, and little to no work has been done to characterize the natural product potential of GSL microbes. Here, we investigate the bacterial diversity of two important regions within GSL, describe the first genomic characterization of Actinomycetota isolated from GSL sediment, including the identification of two new Actinomycetota species, and provide the first survey of the natural product potential of GSL bacteria.

Identifiants

pubmed: 38524762
doi: 10.1093/ismeco/ycae029
pii: ycae029
pmc: PMC10960970
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ycae029

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the International Society for Microbial Ecology.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Elijah R Bring Horvath (ER)

Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, United States.
School of Biological Sciences, University of Utah, Salt Lake City, UT 84112, United States.
Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84112, United States.

William J Brazelton (WJ)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112, United States.

Min Cheol Kim (MC)

Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, CA 92093, United States.

Reiko Cullum (R)

Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, CA 92093, United States.

Matthew A Mulvey (MA)

School of Biological Sciences, University of Utah, Salt Lake City, UT 84112, United States.
Henry Eyring Center for Cell and Genome Science, University of Utah, Salt Lake City, UT 84112, United States.

William Fenical (W)

Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, CA 92093, United States.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, CA 92093, United States.
Moores Comprehensive Cancer Center, University of California at San Diego, CA 92037, United States.

Jaclyn M Winter (JM)

Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, United States.

Classifications MeSH